首页> 外文期刊>International Journal of Experimental Diabetes Research: Experimental Diabesity Research >Novel Role of Parathyroid Hormone-Related Protein in the Pathophysiology of the Diabetic Kidney: Evidence from Experimental and Human Diabetic Nephropathy
【24h】

Novel Role of Parathyroid Hormone-Related Protein in the Pathophysiology of the Diabetic Kidney: Evidence from Experimental and Human Diabetic Nephropathy

机译:甲状旁腺激素相关蛋白在糖尿病肾脏病理生理中的新作用:来自实验性和人类糖尿病性肾病的证据

获取原文
           

摘要

Parathyroid hormone-related protein (PTHrP) and its receptor type 1 (PTH1R) are extensively expressed in the kidney, where they are able to modulate renal function. Renal PTHrP is known to be overexpressed in acute renal injury. Recently, we hypothesized that PTHrP involvement in the mechanisms of renal injury might not be limited to conditions with predominant damage of the renal tubulointerstitium and might be extended to glomerular diseases, such as diabetic nephropathy (DN). In experimental DN, the overexpression of both PTHrP and the PTH1R contributes to the development of renal hypertrophy as well as proteinuria. More recent data have shown, for the first time, that PTHrP is upregulated in the kidney from patients with DN. Collectively, animal and human studies have shown that PTHrP acts as an important mediator of diabetic renal cell hypertrophy by a mechanism which involves the modulation of cell cycle regulatory proteins and TGF-β1. Furthermore, angiotensin II (Ang II), a critical factor in the progression of renal injury, appears to be responsible for PTHrP upregulation in these conditions. These findings provide novel insights into the well-known protective effects of Ang II antagonists in renal diseases, paving the way for new therapeutic approaches.
机译:甲状旁腺激素相关蛋白(PTHrP)及其1型受体(PTH1R)在肾脏中广泛表达,它们能够调节肾功能。已知肾PTHrP在急性肾损伤中过表达。最近,我们假设PTHrP参与肾脏损伤机制可能不限于主要损害肾小管间质的疾病,还可能扩展到肾小球疾病,例如糖尿病性肾病(DN)。在实验性DN中,PTHrP和PTH1R的过度表达都有助于肾脏肥大和蛋白尿的发展。最近的数据首次显示,DN患者的肾脏PTHrP上调。动物和人类研究共同表明,PTHrP通过涉及调节细胞周期调节蛋白和TGF-β1的机制而充当糖尿病肾细胞肥大的重要介质。此外,在这些情况下,血管紧张素II(Ang II)是肾损伤进展的关键因素,似乎是PTHrP上调的原因。这些发现提供了对Ang II拮抗剂在肾脏疾病中众所周知的保护作用的新颖见解,为新的治疗方法铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号